{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:40:25Z","timestamp":1792366825713,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05202-y","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:35:38Z","timestamp":1784716538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lower fibrinogen and fibrinogen-to-albumin ratio in migraine with white matter hyperintensities: implications for microvascular vulnerability"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-186X","authenticated-orcid":false,"given":"Asl\u0131han","family":"Baran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"5202_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1474-4422(14)70220-0","volume":"14","author":"MD Ferrari","year":"2015","unstructured":"Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AM. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015;14:65\u201380.","journal-title":"Lancet Neurol"},{"key":"5202_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3988\/jcn.2021.17.2.164","volume":"17","author":"M Paolucci","year":"2021","unstructured":"Paolucci M, Altamura C, Vernieri F. The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: a narrative review. J Clin Neurol. 2021;17:164\u201375.","journal-title":"J Clin Neurol"},{"key":"5202_CR3","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1161\/STROKEAHA.109.547901","volume":"40","author":"GE Tietjen","year":"2009","unstructured":"Tietjen GE, Herial NA, White L, et al. Migraine and biomarkers of endothelial activation in young women. Stroke. 2009;40:2977\u201382.","journal-title":"Stroke"},{"key":"5202_CR4","doi-asserted-by":"publisher","first-page":"e70063","DOI":"10.1111\/ene.70063","volume":"32","author":"M Ali","year":"2025","unstructured":"Ali M, van der Weerd N, van Os HJA, et al. Coagulation factors and white matter hyperintensities in middle-aged women with and without migraine and ischemic stroke. Eur J Neurol. 2025;32:e70063.","journal-title":"Eur J Neurol"},{"key":"5202_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1468-2982.2007.01467.x","volume":"28","author":"T Kurth","year":"2008","unstructured":"Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia. 2008;28:49\u201356.","journal-title":"Cephalalgia"},{"key":"5202_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/0333102417698936","volume":"38","author":"GE Tietjen","year":"2018","unstructured":"Tietjen GE, Khubchandani J, Herial N, et al. Migraine and vascular disease biomarkers: a population-based case-control study. Cephalalgia. 2018;38:511\u20138.","journal-title":"Cephalalgia"},{"key":"5202_CR7","doi-asserted-by":"publisher","first-page":"e2481","DOI":"10.1212\/WNL.0000000000011931","volume":"96","author":"Y Guo","year":"2021","unstructured":"Guo Y, Rist PM, Sabater-Lleal M, et al. Association between hemostatic profile and migraine: a Mendelian randomization analysis. Neurology. 2021;96:e2481\u20137.","journal-title":"Neurology"},{"issue":"1","key":"5202_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13613-020-00697-1","volume":"22","author":"C Aldecoa","year":"2020","unstructured":"Aldecoa C, Llau JV, Nuvials X, Artigas A. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review. Ann Intensive Care. 2020;22(1):85.","journal-title":"Ann Intensive Care"},{"key":"5202_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","volume":"582","author":"M Roche","year":"2008","unstructured":"Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783\u20137.","journal-title":"FEBS Lett"},{"key":"5202_CR10","doi-asserted-by":"publisher","first-page":"7735","DOI":"10.2147\/JIR.S520602","volume":"12","author":"X He","year":"2025","unstructured":"He X, Wang Y, Wang Y, Li X. Fibrinogen-to-Albumin Ratio as a Novel Predictor of Intracerebral Hemorrhage in Maintenance Hemodialysis Patients. J Inflamm Res. 2025;12:18:7735\u201347.","journal-title":"J Inflamm Res"},{"key":"5202_CR11","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1038\/s41598-021-90341-0","volume":"11","author":"LA Dobrynina","year":"2021","unstructured":"Dobrynina LA, Suslina AD, Gubanova MV, et al. White matter hyperintensity in different migraine subtypes. Sci Rep. 2021;11:10881.","journal-title":"Sci Rep"},{"key":"5202_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jama.291.4.427","volume":"291","author":"MC Kruit","year":"2004","unstructured":"Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427\u201334.","journal-title":"JAMA"},{"key":"5202_CR13","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38:1\u2013211.","DOI":"10.1177\/0333102417738202"},{"key":"5202_CR14","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","volume":"31","author":"A Undas","year":"2011","unstructured":"Undas A, Ari\u00ebns RAS. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011;31:e88\u201399.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5202_CR15","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.20720","volume":"41","author":"GJ Quinlan","year":"2005","unstructured":"Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41:1211\u20139.","journal-title":"Hepatology"},{"key":"5202_CR16","doi-asserted-by":"publisher","first-page":"e70886","DOI":"10.1002\/brb3.70886","volume":"15","author":"G Ha","year":"2025","unstructured":"Ha G, Yan Z, Wu J, et al. Exploring the link between inflammatory biomarkers and migraine in young adults: evidence from NHANES. Brain Behav. 2025;15:e70886.","journal-title":"Brain Behav"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05202-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:13:52Z","timestamp":1792365232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05202-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5202"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05202-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Clinical Research Ethics Committee of Y\u00fcksek \u0130htisas University (approval number: 2023-03). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"653"}}